Alternatively, Caruso et al. reported the generation of allogeneic NK cells engineered to express a second-generation CAR targeting CD123: these CD123 CAR-NK cells displayed a strong cytotoxicity in vitro against primary AML blasts and in vivo in immunodeficient mice AML models [120]. Here, IL3RA is linked to acute myeloid leukemia.